MRC scientists advance understanding of cell deathAugust 14, 2009Research carried out at University of Leicester Medical Research Council (MRC) scientists have made an important advance in understanding the biological processes involved when cells are prompted to die. The work may help scientists to eventually develop new treatments for the many common diseases and conditions which occur when cell death goes wrong. The research, published in leading journal Molecular Cell [1] today (Friday 14 August 2009) was carried out by a team of scientists, at the MRC Toxicology Unit at the University of Leicester and a subsequent patent application has been filed by MRC Technology, the commercial arm of the MRC. Cells in the human body are continually dying and most of these cells kill themselves by a form of cell death, commonly referred to as apoptosis. In a healthy body, the number of cells stays constant. Millions of new cells are produced every second, and millions of others are lost or kill themselves. Failure of the normal apoptosis process plays a role in different diseases including cancer, certain neurodegenerative disorders such as Parkinson's and immune diseases, such as autoimmune lymphoproliferative syndrome (ALPS). One of the study's authors, Dr Marion MacFarlane, MRC Toxicology Unit, explained: "This new research takes us a step closer to understanding how the DISC triggers cells to die. The challenge now is to try and use this fundamental knowledge to help work towards finding better treatments for conditions which occur when DISC-mediated cell death goes wrong." Previous research has shown that a complex called the 'DISC', which is made up of different proteins and is formed following activation of molecules called 'Death Receptors', can trigger apoptosis by 'switching on' key players in the cell death process. However, previous research has found that the DISC can also activate cell survival, thus raising the question as to how paradoxically the 'DISC' can trigger these opposing cellular outcomes? Now, scientists at the MRC Toxicology Unit have found that the DISC can trigger cell death or cell survival by switching the activity of key death-promoting molecules. Stopping the 'DISC' from functioning properly prevents the cell death programme from being carried out efficiently and instead results in cell survival. Thus, in diseases such as ALPS, where a crucial death-promoting protein is often not active the DISC fails to function properly. [1] "Reconstitution of the Death-Inducing Signalling Complex reveals a novel Substrate Switch that determines CD95-mediated Death or Survival" Molecular Cell University of Leicester |
|||||||||||||||||||||
| Related Cell Death Current Events and Cell Death News Articles New understanding about mechanism for cell death after stroke leads to possible therapy Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. UAB Researchers Discover Antibody Receptor Identity, Propose Renaming Immune-System Gene Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. Inhibition of GRK2 is protective against acute cardiac stress injuries Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion. Researchers find potential treatment for Huntington's disease Investigators at Burnham Institute for Medical Research (Burnham), the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington's disease. Research reveals lipids' unexpected role in triggering death of brain cells The lipid that accumulates in brain cells of individuals with an inherited enzyme disorder also drives the cell death that is a hallmark of the disease, according to new research led by St. Jude Children's Research Hospital investigators. Cornell researchers identify a weak link in cancer cell armor The seeming invincibility of cancerous tumors may be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain cells to repair themselves. Sponges recycle carbon to give life to coral reefs Coral reefs support some of the most diverse ecosystems on the planet, yet they thrive in a marine desert. So how do reefs sustain their thriving populations? Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. CSHL team solves structure of NMDA receptor unit that could be drug target for neurological diseases A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor implicated in Alzheimer's, Parkinson's, and other serious illnesses. More Cell Death Current Events and Cell Death News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||